David Loasby
- SEC CIK
- 0001775863
- Latest filing
- Feb 13, 2026
AKBA holding history
Akebia Therapeutics, Inc. in every 13F filed by David Loasby, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AKBA overviewAll 13F holders of AKBAFull Q4 2025 holdings
- Shares (Q4 2025)
- 20,000
- Value
- $28.0K
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 20,000 | $28.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 20,000 | $59.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 20,000 | $74.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 20,000 | $31.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 20,000 | $35.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 20,000 | $26.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 20,000 | $21.6K | <0.1% | +20,000 | New | Holders |